Results 81 to 90 of about 8,393 (209)
Therapeutic intervention strategies in frontotemporal dementia: drug development pipeline
Abstract Frontotemporal dementia (FTD) is the second most common cause of early‐onset dementia after Alzheimer's disease, characterized by substantial genetic, clinical, and pathological heterogeneity. Despite progress in understanding its pathophysiology, no disease‐targeted therapies (DTTs) have been approved to date.
Federica Perrone +9 more
wiley +1 more source
Organic Nitrate-Induced Methemoglobinemia
Metabolism of organic nitrates results in the formation of inorganic nitrites that can oxidize hemoglobin to methemoglobin. Clinical trials have investigated the risk of developing methemoglobinemia during the therapeutic use of organic nitrates.
Jon W. Buenger, Vincent F. Mauro
core +1 more source
A Case Report of Acute-on-Chronic Methemoglobinemia
Introduction: Methemoglobinemia is a rare hematologic disorder of hemoglobin, in which iron contained within the heme moiety becomes oxidized from ferrous iron to ferric iron at a concentration greater than 1% in the blood.
Gabriel Lathrop, Rodney Fullmer
doaj +1 more source
Severe Treatment-Resistant Methemoglobinemia of Unknown Etiology With Recurrence
Discussion: We report a case of a 25-year-old female with repeated admissions with methemoglobinemia. This case highlights the potential for refractory methemoglobinemia requiring repeated treatment, and the importance of longer periods of close ...
James Ainsworth, Suresh Pillai
doaj +1 more source
Nitric oxide generation from nitrate at the cobalt center
Deoxygenation of a cobalt(II) nitrate complex with CO(g) or PPh3 yields a Co(NO)(NO2) species, which can alternatively be generated from a cobalt mononitrosyl complex, featuring a distinct {CoNO}8 core. Abstract Herein, we report the synthesis and reactivity of the cobalt(II) nitrate complex, (acriPNP)Co(NO3) (2).
Jeewon Chun, Yunho Lee
wiley +1 more source
Methemoglobinemia-Induced Acute Kidney Injury
IntroductionMethemoglobinemia refers to the presence of increased levels of methemoglobin (Fe3+) in the blood. Methemoglobinemia can cause cyanosis, dyspnea, fatigue, seizure, arrhythmia, coma, and even death. Although methemoglobinemia is shown to cause
Vachharajani, Tushar +4 more
core +1 more source
AgNPs‐coated PDO sutures were developed by low‐pressure plasma treatment, achieving homogeneous nanoparticle deposition without any significant changes in the polymer's physicochemical properties. The sutures exhibited controlled silver release, activity against S. aureus and E.
Esra Bozkaya
wiley +1 more source
Food-induced methemoglobinemia : a systematic review
Methemoglobinemia is a sporadic, potentially fatal disease of poor tissue oxygenation in which ferrous hemoglobin (Fe 2+) is oxidized to the ferric (Fe3+) state, rendering it incapable of binding oxygen (O2). Fortunately, it is diagnosable and treatable.
Kuchi, Nikhil (S35694) +3 more
core +1 more source
Refractory hypoxia and saturation gap in a COVID-19 patient
Acquired methemoglobinemia, predominantly due to oxidizing medications occurs when heme iron in hemoglobin is oxidized from ferrous to ferric ion and binds oxygen irreversibly leading to functional anemia, cyanosis, and tissue hypoxia.
Abidah Mobarak +4 more
doaj +1 more source
Methemoglobinemia after Local Anesthesia with Prilocaine: A Case Report
Introduction: Methemoglobinemia due to local anesthesia is a rare phenomenon. Grey–blue cyanosis that is unresponsiveto oxygen therapy after the administration of local prilocaine should be considered with methemoglobinemia due to localanesthesia, and ...
Doğan, Halil +4 more
core +1 more source

